Ew Healthcare Partners Fund 2, L.P. - Sep 9, 2021 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role: Other*
Signature: EW HEALTHCARE PARTNERS FUND 2, L.P., By: EW Healthcare Partners Fund 2 GP, L.P., its General Partner, By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter
Stock symbol: TELA
Transactions as of: Sep 9, 2021
Transactions value $: $340,771
Form type: 4
Date filed: 9/13/2021, 02:55 PM
Previous filing: Sep 9, 2021
Next filing: Sep 15, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TELA	Common Stock, par value $0.001 per share	Purchase	$163K	+13.1K	+0.73%	$12.46	1.8M	Sep 9, 2021	See footnotes	F1, F2
transaction	TELA	Common Stock, par value $0.001 per share	Purchase	$178K	+14.4K	+0.8%	$12.31	1.81M	Sep 10, 2021	See footnotes	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 5,321 shares and 5,673 shares of the amount shown above on September 9 and 10, respectively, and Fund 2-A purchased 7,766 shares and 8,763 shares of the amount shown above on September 9 and 10, respectively. Fund 2 now holds a total of 753,185 shares and Fund 2-A now holds a total of 1,058,748 shares of the Issuer.
F2	EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Content

Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 5,321 shares and 5,673 shares of the amount shown above on September 9 and 10, respectively, and Fund 2-A purchased 7,766 shares and 8,763 shares of the amount shown above on September 9 and 10, respectively. Fund 2 now holds a total of 753,185 shares and Fund 2-A now holds a total of 1,058,748 shares of the Issuer.

EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.